0001104659-22-118684.txt : 20221114 0001104659-22-118684.hdr.sgml : 20221114 20221114164859 ACCESSION NUMBER: 0001104659-22-118684 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 EFFECTIVENESS DATE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RiverVest Venture Management LLC CENTRAL INDEX KEY: 0001812549 IRS NUMBER: 431900629 STATE OF INCORPORATION: MO FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-21321 FILM NUMBER: 221386932 BUSINESS ADDRESS: STREET 1: 101 S. HANLEY ROAD STREET 2: SUITE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 314-726-6700 MAIL ADDRESS: STREET 1: 101 S. HANLEY ROAD STREET 2: SUITE 1850 CITY: ST. LOUIS STATE: MO ZIP: 63105 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001812549 XXXXXXXX 09-30-2022 09-30-2022 false RiverVest Venture Management LLC
101 S. Hanley Road Suite 1850 St. Louis MO 63105
13F HOLDINGS REPORT 028-21321 N
Sivan Weitzman Chief Financial Officer 314-726-6700 /s/ Sivan Weitzman St. Louis MO 11-14-2022 0 0 0
INFORMATION TABLE 2 infotable.xml Allakos, Inc. Common 01671P100 29914 4887932 SH OTR 3349223 1538709 0 Spruce Bioscience, Inc. Common 85209E109 2943 2148281 SH SOLE 2148281 0 0 Vapotherm, Inc. Common 922107107 648 412558 SH OTR 0 412558 0 Mirum Pharmaceuticals, Inc. Common 604749101 40363 1921118 SH SOLE 1921118 0 0 Reneo Pharmaceuticals, Inc. Common 75974E103 8071 2409220 SH SOLE 2409220 0 0 Xilio Therapeutics, Inc. Common 98422T100 4195 1441444 SH SOLE 1441444 0 0